People | March 14, 2023
Precision appoints John Hubbard, PhD, as Board of Directors Chair
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
The approved product is indicated for the treatment of adult patients with Multiple myeloma, in combination with Dexamethasone
AstraZeneca and Merck are committed to working with the FDA to bring LYNPARZA in combination with abi/pred to patients diagnosed with mCRPC.
Apixaban Tablets, 2.5 mg and 5 mg had annual sales of USD 18,876 mn in the United States (IQVIA MAT Dec. 2022).
Receives regulatory approval for its molecule ‘Selumetinib’ in India
Amala Hospital partners with LifeSigns to provide revolutionary technology for the first time in the State
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
Subscribe To Our Newsletter & Stay Updated
